Alto Ingredients Earnings Calls
| Release date | May 06, 2026 |
| EPS estimate | -$0.0800 |
| EPS actual | $0.0500 |
| EPS Surprise | 162.50% |
| Revenue estimate | 215.65M |
| Revenue actual | 224.68M |
| Revenue Surprise | 4.19% |
| Release date | Mar 04, 2026 |
| EPS estimate | $0.0200 |
| EPS actual | $0.190 |
| EPS Surprise | 850.00% |
| Revenue estimate | 234.85M |
| Revenue actual | 231.965M |
| Revenue Surprise | -1.23% |
| Release date | Nov 05, 2025 |
| EPS estimate | -$0.0600 |
| EPS actual | $0.190 |
| EPS Surprise | 416.67% |
| Revenue estimate | 234.83M |
| Revenue actual | 240.986M |
| Revenue Surprise | 2.62% |
| Release date | Aug 06, 2025 |
| EPS estimate | -$0.180 |
| EPS actual | -$0.150 |
| EPS Surprise | 16.67% |
| Revenue estimate | 223.606M |
| Revenue actual | 218.436M |
| Revenue Surprise | -2.31% |
Last 4 Quarters for Alto Ingredients
Below you can see how ALTO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $1.04 |
| EPS estimate | -$0.180 |
| EPS actual | -$0.150 |
| EPS surprise | 16.67% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $1.01 |
| Aug 01, 2025 | $1.05 |
| Aug 04, 2025 | $1.03 |
| Aug 05, 2025 | $1.04 |
| Aug 06, 2025 | $1.04 |
| Aug 07, 2025 | $1.00 |
| Aug 08, 2025 | $1.06 |
| Aug 11, 2025 | $1.01 |
| Aug 12, 2025 | $1.04 |
| 4 days before | 2.97% |
| 4 days after | 0% |
| On release day | -3.85% |
| Change in period | 2.97% |
| Release date | Nov 05, 2025 |
| Price on release | $1.16 |
| EPS estimate | -$0.0600 |
| EPS actual | $0.190 |
| EPS surprise | 416.67% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $1.05 |
| Oct 31, 2025 | $1.01 |
| Nov 03, 2025 | $1.04 |
| Nov 04, 2025 | $1.13 |
| Nov 05, 2025 | $1.16 |
| Nov 06, 2025 | $1.42 |
| Nov 07, 2025 | $1.38 |
| Nov 10, 2025 | $1.62 |
| Nov 11, 2025 | $1.78 |
| 4 days before | 10.48% |
| 4 days after | 53.45% |
| On release day | 22.41% |
| Change in period | 69.52% |
| Release date | Mar 04, 2026 |
| Price on release | $2.60 |
| EPS estimate | $0.0200 |
| EPS actual | $0.190 |
| EPS surprise | 850.00% |
| Date | Price |
|---|---|
| Feb 26, 2026 | $2.36 |
| Feb 27, 2026 | $2.28 |
| Mar 02, 2026 | $2.52 |
| Mar 03, 2026 | $2.60 |
| Mar 04, 2026 | $2.60 |
| Mar 05, 2026 | $4.02 |
| Mar 06, 2026 | $4.39 |
| Mar 09, 2026 | $4.37 |
| Mar 10, 2026 | $4.60 |
| 4 days before | 10.17% |
| 4 days after | 76.92% |
| On release day | 54.62% |
| Change in period | 94.92% |
| Release date | May 06, 2026 |
| Price on release | $5.56 |
| EPS estimate | -$0.0800 |
| EPS actual | $0.0500 |
| EPS surprise | 162.50% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $5.52 |
| May 01, 2026 | $5.43 |
| May 04, 2026 | $5.47 |
| May 05, 2026 | $5.99 |
| May 06, 2026 | $5.56 |
| May 07, 2026 | $4.54 |
| May 08, 2026 | $4.46 |
| May 11, 2026 | $4.90 |
| May 12, 2026 | $4.62 |
| 4 days before | 0.725% |
| 4 days after | -16.91% |
| On release day | -18.35% |
| Change in period | -16.30% |
Alto Ingredients Earnings Call Transcript Summary of Q1 2026
Alto Ingredients reported a strong-than-normal Q1 2026 driven by higher export sales, improved crush margins, and recognition of 45Z tax credit proceeds. Consolidated net sales were $225 million (down $2M y/y due to lower volumes), gross profit swung to $9.2 million from a prior-year gross loss, net income was $4.0 million ($0.05/share) vs. a loss of $12 million a year ago, and adjusted EBITDA improved to $4.7 million from negative $4.4 million. Management attributes the improvement to better product mix (higher-value export gallons), a stronger crush margin (~$0.17/gal), unrealized derivative gains on hedges, and cost discipline. Operationally, cold weather and river logistics disruptions caused curtailed production at Pekin and led to some accelerated outage work; Columbia had a planned outage to improve reliability and qualify more gallons for 45Z. Capital projects for 2026 (~$25M planned) include dock repairs and a second alcohol load out at Pekin, adding a third tank at Columbia for liquid CO2, and a debottlenecking at the Pekin dry mill to add ~5 million gallons (~8% capacity) annually. Management is pursuing CO2 utilization and sequestration options at Pekin to lower carbon intensity and capture more 45Z/45Q value, and is encouraged by momentum on year-round E15 (including California) as complementary demand growth. Cash was $20M at quarter end; $16.6M of term loan principal was repaid in Q1 leaving $38.4M outstanding, with $94M total borrowing availability. Near-term priorities: improve utilization and reliability, execute 2026 capex and optimization projects, expand capture of 45Z credits, and monetize biogenic CO2. Management remains cautiously optimistic about market conditions but is monitoring inventory, geopolitics, and demand signals.
Sign In
Buy ALTO